【レポートの概要（一部）】
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Biosimilars: Overview
• Comparative analysis of biosimilars and generics
• Biosimilars market opportunities
• Challenges for new entrants
PART 06: Erythropoietin: An overview
• Clinical uses of EPO
• Abusive uses of EPO
• Risks of EPO use
PART 07: Market landscape
• Market overview
• Five forces analysis
PART 08: Pipeline portfolio
• Phase III pipeline portfolio
• Phase II pipeline portfolio
• Phase I pipeline portfolio
• Pre-clinical pipeline portfolio
PART 09: Marketed products portfolio
PART 10: Market segmentation by end-user
• Hospitals
• Retail pharmacies
PART 11: Market segmentation by application
• End-stage renal disease
• Cancer
• HIV
• Wounds and neural disease
PART 12: Market segmentation by product
• First-generation erythropoietin formulation
• Second-generation erythropoietin formulation
• Biosimilars
PART 13: Geographical segmentation
• Erythropoietin drugs market in EMEA
• Erythropoietin drugs market in Europe
• Erythropoietin drugs market in Americas
• Erythropoietin drugs market in US
• Erythropoietin drugs market in APAC
• Erythropoietin drugs market in China
• Erythropoietin drugs market in Japan
• Market overview
PART 14: Market drivers
• Rise in number of patent expiries
• Need for cost-effective treatment
• Increase in CKD and dialysis patient pool
PART 15: Impact of drivers
PART 16: Market challenges
• Physicians’ reluctance to prescribe biosimilars
• Multiple manufacturing complexities
• Development of alternative therapies
• Complicated regulatory framework
PART 17: Impact of drivers and challenges
PART 18: Market trends
• Advent of biosimilars expected to improve the treatment rates
• Outsourcing of biosimilar manufacturing activities
• High growth in the emerging markets
PART 19: Vendor landscape
• Competitive scenario
• Other prominent vendors
PART 20: Key vendor analysis
• F. Hoffmann-La Roche
• Amgen
• Johnson & Johnson
• Kyowa Hakko Kirin
PART 21: Appendix
• List of abbreviations
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for erythropoietin drugs 2016
Exhibit 03: Impact of key customer segments on the market 2016
Exhibit 04: Definition of biosimilars in different regions
Exhibit 05: Comparison between biosimilars and generics
Exhibit 06: Factors affecting biologics and biosimilars market
Exhibit 07: Impact of biosimilars cost savings on various sectors
Exhibit 08: Factors affecting success of biosimilars
Exhibit 09: Biosimilars industry: Point-of-view
Exhibit 10: Factors influencing uptake of biosimilars
Exhibit 11: Global erythropoietin drugs market: Strategic factors for new biosimilar entrants
Exhibit 12: Challenges for new entrants
Exhibit 13: Historical timeline of EPO development
Exhibit 14: Globally approved EPO biosimilars
Exhibit 15: Overview of global erythropoietin drugs market (2016-2021)
Exhibit 16: Global erythropoietin drugs market 2016-2021 ($ billions)
Exhibit 17: Key strategies in global erythropoietin drugs market
Exhibit 18: Prospects of the global erythropoietin drugs market
Exhibit 19: Global erythropoietin drugs market snapshot: Developed and emerging markets 2016
Exhibit 20: New opportunities in global erythropoietin drugs market
Exhibit 21: Impact of factors affecting the market 2016 and 2021
Exhibit 22: Factors affecting global erythropoietin drugs market
Exhibit 23: Five forces analysis
Exhibit 24: Share of pipeline molecules
Exhibit 25: Pipeline share of biologics and biosimilars in global erythropoietin drugs market 2016
Exhibit 26: Phase III pipeline portfolio
Exhibit 27: Phase II pipeline portfolio
Exhibit 28: Phase I pipeline portfolio
Exhibit 29: Pre-clinical pipeline portfolio
Exhibit 30: Share of biologics and biosimilars in global erythropoietin drugs market 2016
Exhibit 31: Synopsis of marketed products
Exhibit 32: Biosimilars market segmentation by end-user 2016
Exhibit 33: Global erythropoietin drugs market segmentation in by product type 2016
Exhibit 34: Snapshot of global erythropoietin drugs market by geography
Exhibit 35: Erythropoietin drugs market revenue by geography 2016-2021 ($ billions)
Exhibit 36: Overview of erythropoietin drugs market in EMEA (2016)
Exhibit 37: Erythropoietin drugs market in EMEA 2016-2021 ($ billions)
Exhibit 38: Share of erythropoietin drugs market in Europe 2016
Exhibit 39: Erythropoietin drugs market in Europe 2016-2021 ($ billions)
Exhibit 40: Europe erythropoietin drugs market: Opportunity analysis
Exhibit 41: Analysis of erythropoietin biosimilar marketed products in Europe
Exhibit 42: PEST analysis: Erythropoietin drugs market in Europe 2016
Exhibit 43: Overview of erythropoietin drugs market in Americas (2016)
Exhibit 44: Erythropoietin drugs market in Americas 2016-2021 ($ billions)
Exhibit 45: Erythropoietin drugs market in US 2016-2021 ($ billions)
Exhibit 46: Erythropoietin drugs market in US: Opportunity analysis
Exhibit 47: PEST analysis: Erythropoietin drugs market in US
Exhibit 48: Overview of erythropoietin drugs market in APAC (2016)
Exhibit 49: Erythropoietin drugs market in APAC 2016-2021 ($ billions)
Exhibit 50: Market share of erythropoietin drugs in APAC
Exhibit 51: Erythropoietin drugs market in China 2016-2021 ($ millions)
Exhibit 52: China erythropoietin drugs market: Opportunity analysis
Exhibit 53: PEST analysis: Erythropoietin drugs market in China
Exhibit 54: Erythropoietin drugs market in Japan 2016-2021 ($ millions)
Exhibit 55: Erythropoietin drugs market in Japan 2016: Opportunity analysis
Exhibit 56: PEST analysis: Erythropoietin drugs market in Japan 2016
Exhibit 57: Impact of drivers and challenges in global erythropoietin drugs market
Exhibit 58: Patent analysis of biologicals in the US
Exhibit 59: Patent analysis of biologicals in Europe
Exhibit 60: Impact of drivers
Exhibit 61: Key reasons why physicians are reluctant to prescribe biosimilar drugs
Exhibit 62: Approval process of biologicals versus biosimilars via Public Health Service Act (PHSA) in US
Exhibit 63: Impact of drivers and challenges
Exhibit 64: Impact of trends in global erythropoietin drugs market
Exhibit 65: Few biosimilars currently under pipeline
Exhibit 66: Competitive structure analysis of global erythropoietin drugs market 2016
Exhibit 67: Geographical presence of key vendors
Exhibit 68: Competitive scenario: Global erythropoietin drugs market vendors 2016-2021
Exhibit 69: F. Hoffmann La-Roche: Key highlights
Exhibit 70: F. Hoffmann La-Roche: Strength assessment
Exhibit 71: F. Hoffmann La-Roche: Strategy assessment
Exhibit 72: F. Hoffmann La-Roche: Opportunity assessment
Exhibit 73: Amgen: Key highlights
Exhibit 74: Amgen: Strength assessment
Exhibit 75: Amgen: Strategy assessment
Exhibit 76: Amgen: Opportunity assessment
Exhibit 77: Johnson & Johnson: Profile
Exhibit 78: Johnson & Johnson: Strength assessment
Exhibit 79: Johnson & Johnson: Strategy assessment
Exhibit 80: Johnson & Johnson: Opportunity assessment
Exhibit 81: Kyowa Hakko Kirin: Highlights
Exhibit 82: Kyowa Hakko Kirin: Strength assessment
Exhibit 83: Kyowa Hakko Kirin: Strategy assessment
Exhibit 84: Kyowa Hakko Kirin: Opportunity assessment
【レポート販売概要】
■ タイトル：エリスロポエチン（EPO）薬の世界市場2017-2021■ 英文：Global Erythropoietin Drugs Market 2017-2021
■ 発行日：2017年3月7日
■ 調査会社：Technavio
■ 商品コード：IRTNTR12169
■ 調査対象地域：グローバル
- ホームセキュリティシステムの世界市場：セキュリティカメラ、電子/スマートロック、センサー、感知器、アラーム、セキュリティソリューション、DIYホームセキュリティThe rising incidents of security concerns has led to increased safety measures by residential dwellings. As a result, the global home security system market is projected to grow at a remarkable rate of above 13% during the forecast period. Advancement in technology and emergence of smart homes has led to the rise of integrated home security systems, which can be connected to smartphones and enable …
- スターター肥料の世界市場予測（～2022年）The starter fertilizers market is projected to grow at a CAGR of 4.04% from 2016 to 2022, to reach a projected value of USD 8.33 Billion by 2022. Starter fertilizers have become prominent in the recent years, due to the increase in the area under forage & turf grasses, growth in awareness regarding the types of crops that can benefit from the use of starter fertilizers, and increase in research ac …
- 医薬品包装の北米市場ABSTRACTAbout Pharmaceutical Packaging The purpose of packaging products is to protect perishable goods from external damage and contamination. Pharmaceutical packaging products have high-barrier properties and are available in both unit dosage and multi-dosage formats, thereby ensuring the extension of their shelf life. Regulatory bodies for drug manufacturers strictly enforce international juris …
- リンゴ酸の世界市場分析：エンドユーザー別（飲料、菓子、パーソナルケア）、セグメント予測The global malic acid market is expected to reach USD 244.0 million by 2024, according to a new report by Grand View Research, Inc. The expanding food and beverage industry globally is anticipated to be a major factor for substantial industry growth over the next few years. Growing consumer awareness towards obesity issues has led to increased consumption of low-calorie beverages which is expected …
- 眼薬の世界市場予測2016-2026What can be expected from the ophthalmic drugs market? Which companies are going to be most successful in the next 10 years? Which therapeutic areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects in the market. Our 334-page report provides 238 tables, charts, and graphs. Discover the most succ …
- 2-アミノベンゼンチオールの世界市場2-Aminobenzenethiol (CAS 137-07-5) Market Research Report 2013 presents comprehensive data on 2-aminobenzenethiol markets globally and regionally (Europe, Asia, North America etc.) The 2-Aminobenzenethiol (CAS 137-07-5) Market Research Report 2013 includes 2-aminobenzenethiol description, covers its application areas and related patterns. It overviews 2-aminobenzenethiol market, names 2-aminobenze …
- アジアの麻酔器市場Asia-Pacific Anesthesia Machines Market Outlook to 2021 Summary GlobalData’s new report, "Asia-Pacific Anesthesia Machines Market Outlook to 2021", provides key market data on the Asia-Pacific Anesthesia Machines market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Portable Anesthesia Delivery Machines, Sta …
- LTE-Advanced (LTE-A)無線通信技術の世界市場In the last 6 years, the global mobile telecoms industry has been shaped by the introduction of 4G LTE technology. This mobile technology has not only changed the way we communicate, but it has also affected our lives in many different ways from the type of media we watch to the amount of devices we buy. Due to this, the number of deployments and subscriptions of 4G have been booming in the last t …
- 水路測量装備のグローバル市場動向（2014 – 2020）The global hydrographic and equipment market value is expected to reach $2,934.18 million by 2020. The sector demands high-resolution sound and acoustic products and precise positioning systems in the future. The report discusses the hydrographic equipment market in the period from 2014 to 2020. The market has been segmented into four major application areas utilizing the equipment, namely hydrogr …
- 世界のABS樹脂市場（2014-2018）About ABS ABS is an engineering thermoplastic resin composed of styrene, butadiene, and acrylonitrile monomers. Being composed mainly of styrene, and varying ratios of butadiene and acrylonitrile, ABS material can be readily modified in terms of rigidity, hardness and heat resistance, and toughness by varying the monomer proportions. The unique material properties of ABS include impact resistance, …
- 世界の警察近代化及びテロ対策市場（2014-2024）Summary The Global Police Modernization and Counter Terrorism Market 2014-2024 Report published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings • The global Police Modernizati …
- フォトマスクの世界市場2016-2020Photomasks are high-purity quartz or glass plates that contain a pattern of ICs. These are used in the reproduction of pattern structures for manufacturing printed circuit boards, electronic circuits, and LCD displays, and for the serial production of reticles and other microstructures. Photomasks are used at wavelengths of 365 nm, 248 nm, and 193 nm. ICs are manufactured layer by layer, where eac …
- グローバル技術トレンドレポート：ビックデータ及び情報処理（Global Technology Trends Report: Big Data and Extreme Info Processing）Big Data represents more than just a collection of data sets that form a large quantity of data, which is difficult to process using traditional data processing applications. Big Data also represents a big business opportunity across many industry verticals. This report provides comprehensive analysis of big data in several key industry verticals including healthcare, government and telecommunicat …
- グローバルにおけるクラウドコンピューティング市場の現状と将来展望Summary “Current environment and future outlook for cloud computing” is a new report by Kable that globally analyzes usage status, preferred types, key drivers, and major challenges associated with cloud computing, apart from identifying cloud computing services which are currently used and planned for implementation over the next 12 months. This report also examines the annual procurement budget …
- 両心室ペーシング（心臓同期療法/CRT）医療機器のグローバル市場（2012-2018）Global Cardiac Resynchronization Therapy (CRT) sector is projected to reach US$3.1 billion by 2016. The North America accounts for nearly 39% (2015) of the global value while Europe claims approximately 32% (2018). Asia-Pacific is the fastest growing region with a CAGR of 12.8% driving a market value of US$590 million by 2016. On a global scale, projections for Cardiac Resynchronization Therapy De …
